XPH
XPH
About State Street SPDR S&P Pharmaceuticals ETF
The State Street SPDR S&P Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index (the "Index")Seeks to provide exposure to the pharmaceuticals segment of the S&P TMI, which comprises the Pharmaceuticals sub-industrySeeks to track a modified equal weighted index...
About State Street SPDR S&P Pharmaceuticals ETF
The State Street SPDR S&P Pharmaceuticals ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Pharmaceuticals Select Industry Index (the "Index")Seeks to provide exposure to the pharmaceuticals segment of the S&P TMI, which comprises the Pharmaceuticals sub-industrySeeks to track a modified equal weighted index...
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 ELVN | Enliven Therapeutics, Inc. | 2.64% | 205.80K | $9.23M |
 OGN | Organon & Co. | 2.46% | 987.21K | $8.59M |
 CORT | Corcept Therapeutics Incorporated | 2.34% | 187.26K | $8.18M |
 DFTX | Definium Therapeutics, Inc. | 2.13% | 339.14K | $7.44M |
 TRVI | Trevi Therapeutics, Inc. | 2.13% | 529.16K | $7.43M |
 PRGO | Perrigo Company plc | 2.12% | 644.05K | $7.39M |
 AXSM | Axsome Therapeutics, Inc. | 2.09% | 39.61K | $7.30M |
 AMLX | Amylyx Pharmaceuticals, Inc. | 2.05% | 423.18K | $7.16M |
 TERN | Terns Pharmaceuticals, Inc. | 2.04% | 135.06K | $7.11M |
 MBX | MBX Biosciences, Inc. Common Stock | 2.02% | 214.84K | $7.05M |
 NKTR | Nektar Therapeutics | 2.01% | 86.16K | $7.00M |
 JAZZ | Jazz Pharmaceuticals plc | 1.96% | 34.08K | $6.85M |
 INVA | Innoviva, Inc. | 1.95% | 281.81K | $6.82M |
 CRNX | Crinetics Pharmaceuticals, Inc. | 1.95% | 170.86K | $6.79M |
 EWTX | Edgewise Therapeutics, Inc. | 1.94% | 203.87K | $6.76M |
 NUVB | Nuvation Bio Inc. | 1.91% | 1.38M | $6.68M |
 TARS | Tarsus Pharmaceuticals, Inc. | 1.91% | 90.42K | $6.67M |
 LGND | Ligand Pharmaceuticals Incorporated | 1.90% | 28.56K | $6.63M |
 RPRX | Royalty Pharma plc | 1.89% | 135.32K | $6.61M |
 PCRX | Pacira BioSciences, Inc. | 1.88% | 276.75K | $6.57M |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States
Ireland
SingaporeSECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States Ireland SingaporeHoldings (Top 20)
ELVN
Enliven Therapeutics, Inc.
OGN
Organon & Co.
CORT
Corcept Therapeutics Incorporated
DFTX
Definium Therapeutics, Inc.
TRVI
Trevi Therapeutics, Inc.
PRGO
Perrigo Company plc
AXSM
Axsome Therapeutics, Inc.
AMLX
Amylyx Pharmaceuticals, Inc.
TERN
Terns Pharmaceuticals, Inc.
MBX
MBX Biosciences, Inc. Common Stock
NKTR
Nektar Therapeutics
JAZZ
Jazz Pharmaceuticals plc
INVA
Innoviva, Inc.
CRNX
Crinetics Pharmaceuticals, Inc.
EWTX
Edgewise Therapeutics, Inc.
NUVB
Nuvation Bio Inc.
TARS
Tarsus Pharmaceuticals, Inc.
LGND
Ligand Pharmaceuticals Incorporated
RPRX
Royalty Pharma plc
PCRX
Pacira BioSciences, Inc.